CL‐213 1983.
Methods | Trial design: 2‐armed, double‐blind, active‐controlled and stratified RCT Location: Pennsylvania, USA Number of centres: not stated Recruitment period: study commenced in 1979 | |
Participants | Inclusion criteria: male and female schoolchildren in Grades 1 to 6
Exclusion criteria: schoolchildren with a condition which prohibited a thorough oral examination, including orthodontic therapy and extensive prosthetic appliances
Baseline caries: not reported Age at baseline (years): range 6 to 11 years Sex: not reported Any other details of important prognostic factors: background exposure to fluoride not reported. Community water supply fluoride < 0.3 ppm Number randomised: not reported Number evaluated: 1197 at 3 years (present for final assessment. Gp A: 582; Gp B: 615) Attrition: unable to calculate due to missing information from number randomised |
|
Interventions | Comparison: FT versus FT Gp A (n = 582 evaluated): NaF 1100 ppm F; abrasive system not reported; home use ad libitum (twice daily, unsupervised assumed) Gp B (n = 615 evaluated): NaF 1700 ppm F; abrasive system not reported; home use ad libitum (twice daily, unsupervised assumed) | |
Outcomes | Primary: 3‐year DMFS increment ‐ cl + xr Secondary: none reported Assessments irrelevant to this review's scope: none Follow‐up duration: 3 years | |
Notes | Adverse effects: not reported Funding source: The Procter & Gamble Company Declarations/conflicts of interest: none reported. Procter & Gamble data Data handling by review authors: n/a Other information of note: all clinical (Radike criteria) and radiographic examinations were carried out by a single examiner. "The sponsor decided to begin another study immediately upon completion of the Year 3 examinations. For logistical reasons, it was decided to only perform Year 3 examinations on those subjects who agreed to participate in Study E (approximately 40% to 45% of the subjects who completed Year 2)." Unpublished data on file from The Procter & Gamble Company, published in Bartizek 2001 | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Quote: "...subjects were stratified based on gender, age and baseline DMFS scores derived from the visual‐tactile examination, and randomly assigned to one of the treatment groups in the study" |
Allocation concealment (selection bias) | Unclear risk | Comment: insufficient information |
Blinding (performance bias and detection bias) All outcomes | Low risk | Quotes: "... double‐blind study" "Subject and examiner blindness to treatment were maintained throughout the study" and "Dentifrices were supplied in plain white tubes" |
Incomplete outcome data (attrition bias) All outcomes | High risk | Quotes: "The studies each enrolled approximately 1200 to 2000 male and female schoolchildren per treatment group" and "The sponsor decided to begin another study immediately upon completion of the Year 3 examinations. For logistical reasons, it was decided to only perform Year 3 examinations on those subjects who agreed to participate in Study E (approximately 40% to 45% of the subjects who completed Year 2)" Comment: actual number randomised not reported, so unable to calculate attrition. Selective examination at Year 3 |
Selective reporting (reporting bias) | Low risk | Comment: results reported traditional increment using clinical and radiographic assessments |
Baseline characteristics balanced? | Low risk | Comment: not explicitly stated, but stratified randomisation according to gender, age and baseline DMFS scores with large sample size so probably balanced |
Free of contamination/co‐intervention? | Low risk | Quote: "...siblings, all were automatically assigned to the same treatment group as the first sibling to minimise the risk from cross‐usage of assigned dentifrice" |